Obesity drug reduced weight by 20% in 72 weeks. This is a record

The phase three study involved 2,539 people. Scientists assessed the effectiveness and safety

tircepatide for obese adults oroverweight. Tirzepatide successfully completed its objectives - it helped participants reduce body weight, and the number of people who lost weight by more than 5% of their initial weight also increased.

The molecule of this drug imitates the work of a glucose-dependent insulinotropic polypeptide. Early research has shown that it helps reduce food intake and increase energy expenditure.

Each participant was randomly assigned to one offour groups: tirzepatide 5 mg, 10 mg or 15 mg or placebo. Treatment included one subcutaneous injection of the drug every week. The more the drug a person took, the more weight decreased. On average, volunteers lost 16% of their original body weight.

Tirsepatide officially submitted to the FDA at the endlast year as a cure for diabetes. Based on the successful results of the phase 3 study, approval of the drug is expected to occur within the next few months.

Read more:

It has been hunted for centuries: what do we know about the planet Vulcan next to the Sun

Physicists have experimentally confirmed a new fundamental law for liquids

Astronomers have found a planet near the Earth: it has a very strange orbit